Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Grander

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|August 18, 2021
Hepatic Meteorin-like and Krüppel-like Factor 3 are Associated with Weight Loss and Liver InjuryChristoph Grander, Felix Grabherr, Barbara Enrich, et al.
BMJ Open Gastroenterology|July 16, 2020
Liver stiffness by transient elastography accompanies illness severity in COVID-19Maria Effenberger, Christoph Grander, Gernot Fritsche, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 3, 2020
Systemic inflammation as fuel for acute liver injury in COVID-19Maria Effenberger, Christoph Grander, Felix Grabherr, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 20, 2020
Dimethyl fumarate ameliorates hepatic inflammation in alcohol related liver diseaseMoris Sangineto, Felix Grabherr, Timon E Adolph, et al.
Gut Microbes|July 5, 2022
Recovery of <i>Bacteroides thetaiotaomicron</i> ameliorates hepatic steatosis in experimental alcohol-related liver diseaseMoris Sangineto, Christoph Grander, Felix Grabherr, et al.
Gut|September 8, 2017
NAD metabolism fuels human and mouse intestinal inflammationRomana R Gerner, Victoria Klepsch, Sophie Macheiner, et al.
Journal of Translational Medicine|December 6, 2019
Microbiota, type 2 diabetes and non-alcoholic fatty liver disease: protocol of an observational studyBenedetta M Motta, Christoph Grander, Martin Gögele, et al.
JHEP Reports : Innovation in Hepatology|October 11, 2023
24-Norursodeoxycholic acid ameliorates experimental alcohol-related liver disease and activates hepatic PPARγChristoph Grander, Moritz Meyer, Daniel Steinacher, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 2, 2017
Ethanol-mediated suppression of IL-37 licenses alcoholic liver diseaseFelix Grabherr, Christoph Grander, Timon E Adolph, et al.
Journal of Hepatology|December 20, 2015
Lipocalin 2 drives neutrophilic inflammation in alcoholic liver diseaseVerena Wieser, Piotr Tymoszuk, Timon Erik Adolph, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|August 18, 2021
Hepatic Meteorin-like and Krüppel-like Factor 3 are Associated with Weight Loss and Liver InjuryChristoph Grander, Felix Grabherr, Barbara Enrich, et al.
BMJ Open Gastroenterology|July 16, 2020
Liver stiffness by transient elastography accompanies illness severity in COVID-19Maria Effenberger, Christoph Grander, Gernot Fritsche, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 3, 2020
Systemic inflammation as fuel for acute liver injury in COVID-19Maria Effenberger, Christoph Grander, Felix Grabherr, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 20, 2020
Dimethyl fumarate ameliorates hepatic inflammation in alcohol related liver diseaseMoris Sangineto, Felix Grabherr, Timon E Adolph, et al.
Gut Microbes|July 5, 2022
Recovery of <i>Bacteroides thetaiotaomicron</i> ameliorates hepatic steatosis in experimental alcohol-related liver diseaseMoris Sangineto, Christoph Grander, Felix Grabherr, et al.
Gut|September 8, 2017
NAD metabolism fuels human and mouse intestinal inflammationRomana R Gerner, Victoria Klepsch, Sophie Macheiner, et al.
Journal of Translational Medicine|December 6, 2019
Microbiota, type 2 diabetes and non-alcoholic fatty liver disease: protocol of an observational studyBenedetta M Motta, Christoph Grander, Martin Gögele, et al.
JHEP Reports : Innovation in Hepatology|October 11, 2023
24-Norursodeoxycholic acid ameliorates experimental alcohol-related liver disease and activates hepatic PPARγChristoph Grander, Moritz Meyer, Daniel Steinacher, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 2, 2017
Ethanol-mediated suppression of IL-37 licenses alcoholic liver diseaseFelix Grabherr, Christoph Grander, Timon E Adolph, et al.
Journal of Hepatology|December 20, 2015
Lipocalin 2 drives neutrophilic inflammation in alcoholic liver diseaseVerena Wieser, Piotr Tymoszuk, Timon Erik Adolph, et al.
Pageof 4